share_log

Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying

Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying

Clearside Biomedical 和其他三隻細價股內部人士正在買入
Benzinga ·  05/16 07:55

The Dow Jones index closed higher by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週三收高約350點。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息,請訪問Benzinga的內幕交易平台。

Sabre

軍刀

  • The Trade: Sabre Corporation (NASDAQ:SABR) Executive Vice President Roshan Mendis bought a total of 31,067 shares at an average price of $3.15. To acquire these shares, it cost around $97,802.
  • What's Happening: On May 2, Sabre reported better-than-expected first-quarter results and updated FY24 revenue outlook.
  • What Sabre Does: Sabre holds the number-two air booking volume share in the global distribution system industry.
  • 交易:Sabre公司(納斯達克股票代碼:SABR)執行副總裁羅珊·門迪斯共購買了31,067股股票,平均價格爲3.15美元。收購這些股票的成本約爲97,802美元。
  • 發生了什麼:5月2日,Sabre公佈了好於預期的第一季度業績和最新的24財年收入展望。
  • Sabre做什麼:Sabre在全球分銷系統行業的航空預訂量份額中排名第二。

Zomedica

Zomedica

  • The Trade: Zomedica Corp. (NYSE:ZOM) Director Johnny D Powers acquired a total of 50,000 shares at an average price of $0.14. To acquire these shares, it cost around $6,981.
  • What's Happening: On May 15, Zomedica announced the launch of Over-the-Air software and firmware update capability for its TRUFORMA point-of-care diagnostic platform..
  • What Zomedica Does: Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians.
  • 交易:Zomedica Corp.(紐約證券交易所代碼:ZOM)董事Johnny D Powers共收購了5萬股股票,平均價格爲0.14美元。收購這些股票的成本約爲6,981美元。
  • 發生了什麼:5月15日,Zomedica宣佈爲其TRUFORMA即時診斷平台推出無線軟件和固件更新功能。
  • Zomedica做什麼:Zomedica Corp是一家獸醫健康公司,專注於臨床獸醫未滿足的需求,爲伴侶動物(犬、貓和馬)生產產品。

Clearside Biomedical

克利爾賽德生物醫

  • The Trade: Clearside Biomedical, Inc. (NASDAQ:CLSD) Director Benjamin R Yerxa acquired a total of 7,813 shares at an average price of $1.31. The insider spent around $10,235 to buy those shares.
  • What's Happening: On May 9, Clearside Biomedical reported worse-than-expected first-quarter financial results.
  • What Clearside Biomedical Does: Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company.
  • 交易:Clearside Biomedical, Inc.(納斯達克股票代碼:CLSD)董事本傑明·耶爾克薩共收購了7,813股股票,平均價格爲1.31美元。知情人士花費了約10,235美元購買了這些股票。
  • 發生了什麼:5月9日,Clearside Biomedical公佈的第一季度財務業績低於預期。
  • Clearside Biomedical的所作所爲:Clearside Biomedical Inc是一家總部位於美國的臨床生物製藥公司。

Lipella Pharmaceuticals

利佩拉制藥

  • The Trade: Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) 10% owner Jonathan H Kaufman acquired a total of 10,000 shares at an average price of $0.76. The insider spent around $7,590 to buy those shares.
  • What's Happening: On April 17, Lipella Pharmaceuticals expanded its advisory board to include oncology expertise.
  • What Lipella Pharmaceuticals Does: Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company.
  • 交易:利佩拉制藥公司(納斯達克股票代碼:LIPO)10%的所有者喬納森·考夫曼以0.76美元的平均價格共收購了1萬股股票。知情人士花費了約7,590美元購買了這些股票。
  • 發生了什麼:4月17日,利佩拉制藥擴大了其顧問委員會,將腫瘤學專業知識納入其中。
  • 利佩拉制藥公司做什麼:利佩拉制藥公司是一家臨床階段的生物技術公司。

Read This: Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing

閱讀這篇文章:吉姆·克萊默:這家工業公司 “絕對太棒了”,建議收購摩丁製造公司

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論